Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
United Therapeutics Says FDA Accepts Supplemental Filing for Nebulized Tyvaso in IPF

United Therapeutics Says FDA Accepts Supplemental Filing for Nebulized Tyvaso in IPF

MT newswireMT newswire2026/09/02 11:25
07:25 AM EDT, 09/02/2026 (MT Newswires) -- United Therapeutics (UTHR) said Wednesday the US Food and Drug Administration has accepted its supplemental new drug application for nebulized Tyvaso inhalation solution to treat idiopathic pulmonary fibrosis, or IPF. The application was based on the combined analyses of the results of two phase 3 studies that showed nebulized Tyvaso demonstrated "statistically significant superiority" over placebo, the company said. United Therapeutics said it expects the FDA to complete its review of the application in late April 2027.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Meta (META.US) data center's first high-yield bond is oversubscribed more than four times, strong demand drives premium issuance

The first junk bond issuance by the data center division of Meta Platforms attracted demand over four times the transaction size, with its enticing yields drawing in investors.

智通财经2026/09/19 04:11

US stock index adjustments to take effect next Monday: Bloom Energy (BE.US) and Everpure (P.US) to be included in S&P 500, changes also for mid- and small-cap stocks

Bloom Energy, Illumina, and Everpure will be included in the S&P 500 index, while several other companies will be added to the S&P 100, S&P MidCap 400, and S&P SmallCap 600 indices.

智通财经2026/09/19 02:31